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Abstract.  A  subpopulation of the largest subunit of 
RNA polymerase II (Pol II LS) is located in 20-50 
discrete subnuclear domains that are closely linked to 
speckle domains, which store splicing proteins. The 
speckle-associated fraction of Pol 17 LS is hyper- 
phosphorylated on the COOH-terminal domain 
(CTD), and it is highly resistant to extraction by de- 
tergents. A diffuse nucleoplasmic fraction of Pol II LS 
is relatively hypophosphorylated on the CTD, and it is 
easily extracted by detergents. In transcriptionally ac- 
tive nuclei, speckle bound hyperphosphorylated Pol II 
LS molecules are distributed in irregularly shaped 
speckle domains, which appear to be interconnected 
via a reticular network. When transcription is in- 
hibited, hyperphosphorylated Pol II LS and splicing 
protein SC35 accumulate in speckle domains, which 
are transformed into enlarged, dot-like structures lack- 
ing interconnections. When cells are released from 
transcriptional inhibition, Pol II0 and SC35 redistrib- 
ute back to the interconnected speckle pattern of tran- 
scriptionally active cells. The redistribution of Pol II 
and SC35 is synchronous, reversible, and temperature 
dependent. It is concluded that:  (a) hyperphosphoryla- 
tion of Pol II LS's CTD is a better indicator of its 
tight association to discrete subnuclear domains than 
its transcriptional activity; (b) during states of tran- 
scriptional inhibition, hyperphosphorylated Pol II LS 
can be stored in enlarged speckle domains, which un- 
der the light microscope appear to coincide with the 
storage sites for splicing proteins; and (c) Pol II and 
splicing proteins redistribute simultaneously according 
to the overall transcriptional activity of the nucleus. 
NA polymerase II transcripts  (pre-mRNAs)  are co- 
transcriptionally  spliced  and  packaged  into  ribo- 
nucleoprotein (RNP) t particles in diverse eukaryotic 
nuclei (Sass and Pederson,  1984; Beyer and Osheim, 1988; 
Fakan et ai., 1986; Huang and Spector, 1991; Matunis et al., 
1993; Weeks et al., 1993; Baur6n and Wieslander, 1994; for 
review see Beyer and Osheim, 1991). In mammalian cells, 
many proteins and snRNAs that participate  in pre-mRNA 
splicing  are highly concentrated in irregularly shaped  in- 
tranuclear regions termed "speckle domains" (for review see 
Spector,  1993). Most nuclei have 20-50 speckle domains, 
which can be visualized by immunofluorescence  microscopy 
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1. Abbreviations  used in this paper: CTD, COOH-terminal domain; DPBS, 
Duibecco's  phosphate  buffered  saline;  DOC,  deoxycholate;  DRB,  5,6- 
dichlorobenzimidazole  riboside;  ICGCs,  interchromatin  granule clusters; 
PCF, perichromatin  fibrils; Poi II LS, RNA polymerase lI large subunit; 
Pol  IIA, hypophosphorylated  form  ('~220  kD)  of RNA polymerase  II 
largest  subunit;  Pol II0, hypcrphosphorylated  form (,x,240 kD)  of RNA 
polymerase  II largest subunit;  RNP, ribonucleoprotein;  SR protein,  Ser- 
ine/Arginine  family splicing protein;  TD buffer, Tris-HCl/Deoxycholate 
buffer. 
using antibodies directed against a subset of hnRNPs (Fakan 
et al.,  1984), snRNPs (Lerner et al.,  1981; Spector et al., 
1983, 1991; Fakan et ai., 1984; Nyman et al., 1986; Verhei- 
jen et al., 1986; Habets et al., 1989), and non-snRNP splic- 
ing proteins of the SerArg (SR) family, such as spliceosome 
assembly factor (SC35) (Fu and Maniatas,  1990; Spector et 
al., 1991; Roth et al., 1991; Xing et al., 1993; Carter et al., 
1993).  Nuclear  speckle  domains  can  also  be  visualized 
by fluorescent in situ hybridization  using  oligonucleotide 
probes complementary  to spliceosomal snRNAs (Huang and 
Spector,  1992; Carmo-Fonseca et al.,  1992). At the ultra- 
structural level, discrete structures termed "interchromatin 
granule clusters" (ICGCs)  are highly enriched with SC35 
and several other macromolecules localized in speckles by 
light  microscopic techniques.  Less  prominent SC35 im- 
munolabeling  is present in "perichromatin  fibrils" (PCFs), 
which form a latticework in the nucleoplasm surrounding the 
ICGCs. The intense SC35 labeling in the ICGCs, combined 
with the weak SC35 labeling in the surrounding  PCF net- 
work,  correlates well  with  light  microscopic images  of 
SC35-stained  speckles, which appear to be interconnected 
and irregularly shaped (Spector,  1993). 
ICGCs contain many proteins and RNPs known to partici- 
pate direcdy in pre-mRNA splicing reactions, so it is likely 
that partially or fully assembled spliceosomes are located in 
these regions (Spector,  1993; Rosbash and Singer,  1993). 
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1991, 1993), raising the possibility that RNA polymerase II 
(Pol II)-mediated transcription and/or splicing take place 
within the  ICGCs.  However,  RNA  labeling  studies have 
repeatedly shown that Pol II transcription takes place in nu- 
clear sites which are separate from the ICGCs. For example, 
the PCFs and nucleoplasm surrounding the ICGCs are la- 
beled strongly and rapidly with [3H]uridine,  but the ICGCs 
are labeled poorly (Fakan and Bernhard, 1971; Fakan et al., 
1976;  Fakan and Nobis,  1978;  Fakan and Puvion,  1980; 
Spector,  1990).  Recent  studies  using  5'  bromouridine 5' 
triphosphate  to  label  nascent  Pol  II  transcripts  revealed 
100-500 discrete Pol II transcription foci that are widely dis- 
tributed in the nucleus (Jackson et al., 1993; Wansink et ai., 
1993). These focal transcription sites are resistant to nucleo- 
lytic treatments which remove ~90 % of  the chromatin, indi- 
cating that Pol II-mediated transcription is associated with 
a  solid  phase  nuclear  structure  (Jackson  et  al.,  1993). 
Furthermore, the transcription foci are  separate from the 
regions most enriched with SC35  (i.e., ICGCs), although 
weaker SC35 labeling coincides with transcription foci (Wan- 
sink et al., 1993). Thus, light and electron microscopic tech- 
niques have shown that Pol II transcription takes place out- 
side  of the  regions  that are  most enriched with  splicing 
proteins (ICGCs). 
Several studies imply that ICGCs are storage/reassembly 
sites for splicing proteins. ICGCs are comprised of many of 
the same splicing molecules found in spherical organelles 
termed "B-snurposomes" in the amphibian germinal vesicle 
(Gall, 1991; Wu et al.,  1991). B-snurposomes are adjacent 
to transcriptionally active chromatin, but they are not di- 
rectly connected to  the  chromosome loops,  so  these  or- 
ganelles store spliceosomal complexes that are not engaged 
in splicing. Because B-snurposomes and ICGCs have a very 
similar composition, and both are located in interchromatin 
nuclear regions, they are probably analogous structurally 
and functionally. Perhaps the most compelling evidence that 
ICGCs are storage sites for splicing proteins is that these 
structures become enlarged when there is reduction in splic- 
ing activity. Thus, inhibition of transcription or splicing in- 
duces SR proteins (e.g., such as SC35) to accumulate in en- 
larged ICGCs, and coincidentally, anti-SR immunolabeling 
is diminished in the PCFs surrounding the ICGCs (O'Keefe 
et al.,  1994).  At the light microscopic level of resolution, 
SC35-1abeled speckles undergo a striking reorganization that 
reflects the overall transcriptional activity of the nucleus: the 
irregularly shaped, interconnected speckles of transcription- 
ally active nuclei are converted into enlarged, round uncon- 
nected speckles of transcriptionally inactive nuclei (O'Keefe 
et al.,  1994). 
Given that splicing proteins are stored or reassembled in 
ICGCs, there is presumably a mechanism to dispatch them 
from these domains to the sites of Pol II transcription. In 
support of this idea, SC35 redistributes from the ICGCs to 
Pol II gene templates introduced into the nucleus by viral in- 
fection or  by  plasmid  transfection (Bridge  et  al.,  1993; 
Jimtnez-Garcia  and  Spector,  1993;  Rice  et  al.,  1994). 
Significantly, hnRNPs and the large subunit of RNA poly- 
merase II (Pol II LS) are also recruited to sites of gene tran- 
scription, indicating that Pol II transcription and pre-mRNA 
processing  reactions  are  linked  spatially  and  temporally 
(Jimtnez-Garcia and Spector, 1993). These observations im- 
ply that there is a mechanism which coordinately recruits Pol 
II LS and splicing proteins to genes. Pol II and splicing pro- 
teins may be recruited from separate intranuclear compart- 
ments. Alternatively, they may be recruited from a common 
compartment to the sites of Pol II transcription. To distin- 
quish between these two possibilities, it is essential to pre- 
cisely define the subnuclear distribution of  Pol II and splicing 
proteins during states of transcriptional activity and quies- 
cence. 
The present study shows that a subpopulation of  the largest 
subunit of Pol II (Pol II LS) and splicing protein SC35 are 
located in nuclear speckle domains, and they are tightly as- 
sociated with a  solid phase nuclear structure. When tran- 
scription is inhibited, SC35 and Pol II LS accumulate in en- 
larged speckle domains lacking interconnections. When the 
cells are released from transcriptional inhibition, Pol II LS 
and SC35 rapidly and simultaneously redistribute back to an 
interconnected speckle pattern which is characteristic of ac- 
tively  transcribing  nuclei.  Throughout  the  redistribution 
cycle, Pol II LS and SC35  remain tightly associated with 
discrete nuclear regions. During states of transcriptional ac- 
tivity and quiescence, the solid phase associated fraction of 
Pol II LS is hyperphosphorylated on the COOH-terminal do- 
main (CTD). However, the easily extracted and diffusely  dis- 
tributed fraction of Pol II LS is hypophosphorylated to vari- 
ous degrees on the CTD.  We conclude that under certain 
conditions, hyperphosphorylated Pol II LS molecules are 
stored in speckle domains, and that hyperphosphorylation  of 
Pol II LS's CTD correlates more closely with its distribution 
to discrete subnuclear domains than its transcriptional activ- 
ity. The present study shows that the storage sites for Pol II 
LS are organized in a pattern that is very similar to the stor- 
age sites for splicing proteins. 
Materials and Methods 
Immunopurification of  Pol II 240 and 140 kD Subunits 
The  240-kD  and  140-kD subunits  of RNA  polymerase  were  immuno- 
purified  from  the  nuclei  of 60  rat  livers  (700  g)  using a  modification 
of an established nuclear fractionation procedure (Nickerson et al., 1992). 
Fresh minced livers were homogenized in a glass vessel with a rotating 
Teflon pestle in 10 ml/g liver ice cold CSK-100  buffer (100 mM NaCI, 0.3 M 
Sucrose, 3 mM MgCI2, 10 mM Pipes, pH 6.8, 1 mM EGTA, and 0.5% 
Triton X-100) to which was added 1 mM PMSF. The nuclei were collected 
by centrifugation at 200 g at 4°C, washed with several changes of CSK-100, 
and resuspended in 1.5 ml/g liver of CSK-50 buffer (50 mM NaCI) and in- 
cubated with 110 pg/ml deoxyribonuclease (Sigma Chem. Co., St. Louis, 
MO; cat. No. DN25) at 22°C for 30 min, and then pelletted at 200 g. The 
nuclei were then extracted in either of two ways. To maximize the yield of 
the 240-kD subunit, the nuclear pellet was resuspended in 0.3 vol of TBS 
(50 mM Tris-HC1 7.4, 150 mM NaCI, 1 mM PMSF), and then 3.3% SDS 
in TBS was added dropwise to a final concentration of 1% SDS. The suspen- 
sion was heated in a boiling water bath for 5 min, passed repeatedly through 
a 19-gauge needle to shear chromosomal DNA, and then diluted with 6 vol 
of  ice cold Py20 lysis buffer (50 mM Tris HCI, pH 7.4, 150 mM NaCI, 0.5 % 
Triton X-100, 0.5% Sodium deoxycholate, and 1 raM PMSF). To immuno- 
precipitate a complex of  proteins including 1)240 and p140, the nuclear pellet 
was resuspended in 10 vol of TD buffer (50 mM "Iris HCI, pH 7.5, 0.5% 
Triton X-100, 0.5% Sodium deoxycholate (DOC),  250 mM NaCI, 5 mM 
EDTA, 50 mM NaE  1 mM PMSE 1 mM Sodium orthovanadate, 5 mM 
/3-glycerophosphate; Warren et al., 1992). Insoluble material was removed 
via centrifugation at 16,000 g at 4°C for 20 rain. Pol H was then immunopre- 
cipitated with mAb H5 coupled to protein G Sepharose 4 Fast Flow beads 
(Pharmacia LKB Biotechnolugy, Piscataway, NJ). Coupling was performed 
as follows: 50/zg of  IgM mAb H5, 33/zg of rabbit anti-mouse IgM (Zymed 
Labs, San Francisco, CA) and 66/~1 of Protein G beads per rat liver were 
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were pelleted by eentrifugation at 250 g and washed with TBS before being 
added to the 16,000-g supernatant. Immunoprecipitation was performed 
rocking end over end at 4"C for 16 h, the beads were washed three times 
with TD buffer, and the immunoprecipitated protein was eluted by incubat- 
ing with 1.5 times the bead volume of sample buffer (3% SDS, 2 M urea, 
62.5 M Tris HCI, pH 6.9, 2 mM EDTA,  and 3.5%  (vol/vol) 2-mercap- 
toethanol) at 100*C for 5 rain. The beads were discarded and the ehiate was 
lyophilized and resuspended in 17 #1 per rat liver of 62.5 mM "Iris, pH 6.8, 
2 mM EDTA,  10% glycerol  and 3.5%  (vol/vol) 2-mereaptoethanol. The 
proteins were then resolved by 8% SDS-PAGE (Laemmli,  1970). 
Microsequence Determination 
The 240- and 140-kD hands were cut out of the gel and submitted to the 
W.  M.  Keck foundation Biotechnology Resource  laboratory at the Yale 
School  of  Medicine  for  microsequence analysis  (Stone and  Williams, 
1994). Briefly, the two protein samples were digested with trypsin at 37°C 
for 24 h, and then eluted from the gel by incubating with 2 M urea, 0.1 M 
NI-I4CO3 at  37"C  for  another  24  h.  The  samples  were  lyophilized, 
resuspended in H20, and then subjected to HPLC.  Several tryptic peptides 
eluted from the reverse phase HPLC column were then subjected  to laser 
desorption mass spectroscopy  to assess  homogeneity.  Subsequently  two 
peptides from the 240-kD protein and one from the 140-kD protein were 
subjected to microsequence analysis  via automated Edman degradation. 
Cell Culture 
MDCK  cells  were  maintained in  monolayer  culture  with  DME  sup- 
plemented with 7 % FBS. HeLa cells were maintained in monolayer culture 
with RPMI 1640 medium supplemented with 7% FBS and 10 mM gluta- 
mine (GIBCO BRL, Gaithersburg, MD). Where indicated,  the following 
transcriptional inhibitors (purchased from Sigma Chem. Co.) were added 
to the culture media at the indicated final concentrations and times: alpha 
amanitin (10 t~g/ml, 8 h); 5,6-dichlorobenzimidazole  riboside (DRB,  100 
~tM,  3  h); actinomycin D  (20 ~g/ml, 2  h); N-(2[methylamino]ethyl)-5- 
isoquinolinesulfonamide (H8,  100 #M, 2 h). 
Antibodies 
The generation and initial characte  "rmation of monoclonal IgM antibodies 
H5 and HI4 are described elsewhere (Warren et al., 1992; Bregman et al., 
1994). 8WG16 (Promega,  Madison, WI) is a mouse monoclonal IgG anti- 
body that binds to the COOH-terminal domain (CTD) of RNA polymerase 
II (Thompson et al., 1989). ARNA3 (Research Diagnostics,  Flanders, NJ) 
is a mouse monoclonal IgG antibody that binds to the non-CTD part of 
RNA polymerase II (~er  et ai., 1980). SC35 (Amer. "Pype  Culture Col- 
lection, Rockville, MD) is a mouse monoclonal IgG antibody that binds to 
a phosphorylated epitope within the highly reiterated Scrine/Arginine (SR) 
domain of spliceosome assembly factor (SC35), a member of the SR family 
of non-snRNP-splicing proteins (Fu and Maniatas, 1990). mAbs H22 and 
MOPC  104 are antibody controls.  1-I22 is a mouse monoclonal IgM that 
binds to an unidentified  'x,180-kD protein in MDCK cells (unpublished 
results).  MOPC104 (Sigma Chem. Co.) is a mouse monoclonal IgM anti- 
body that binds to a-l, 3 glucoside residues within polysaccharide epitopes. 
lmmunoprecipitation  and Immunoblotting 
MDCK protein extracts  suitable for immunoprecipitation were prepared 
using hot "1% SDS  lysis buffer"  followed by dilution with "0.5%  Triton 
X-100/0.5 % deoxycholate dilution buffer  ~ as described previously (Warren et 
al.,  1992). Immunoprecipitations were performed using IgM mAbs H22, 
HI4, and H5 coupled to protein G Sepharose beads via a rabbit anti-mouse 
IgM linker antibody (see  Immunopurification of Pol II subunits  above). 
Whole cell extracts were obtained by scraping cells from nearly confluent 
culture dishes into hot 2× sample buffer and heating the sample to 100°C 
for 5 min, and then shearing chromosomal DNA with a 19-gauge syringe. 
Immunoprecipitates as well as whole cell extracts  were resolved by 8 % 
SDS-PAGE and transferred to nitrocellulose as described (Laernmli,  1970; 
Towbin et al., 1979). Nitrocellulose  filters were incubated overnight at 40C 
in blocking buffer (TBS with 3% [wt/vol] BSA [>98% pure, Sigma Chem. 
Co.]), and then incubated 2-6 h at room temperature with 2/:g/rnl H5, 2 
t~g/ml MOPC  104  (Sigma  Chem.  Co.),  or  1 t~g/ml 8WG16 (Promega) 
diluted in blocking buffer or with HI4 hybridoma supernatant. Unbound an- 
tibody was removed by multiple washes with TBS-O.05  % Tween 20 at room 
temperature, and then the filters were incubated with horseradish peroxi- 
dase-conjugated goat anti-mouse IgM (for H5, MOPC 104, and H14) or 
horseradish  peroxidase-conjugated  goat  anti-mouse  IgG  (for  8WGI6) 
(KPL,  Gaithersburg,  MD) diluted 1:12,500 in blocking buffer for 1 h at 
room temperature.  Unbound antibody was removed by washing  with TBS- 
0.05% Tween 20 and bound antibody was visualized by enhanced chemilu- 
minescence using hyperfilm (Amersham Corp., Arlington Heights,  IL). 
lmmunofluorescence Microscopy 
Imrnunothiorescence  microscopy  and photography was performed essen- 
tially as described previously (Warren et al., 1992; Bregman et al., 1994). 
Briefly, cells grown on coverslips  were either fixed with 1.75% parafor- 
maldehyde,  and then permeabilized with 0.5%  Triton X-100 or permeabi- 
lized with 1-1.5% Triton X-100, and then fixed with 1.75% paraformalde- 
hyde. Nonspecific-binding  sites were blocked by incubating coverslips with 
4% BSA in Dulbecco's phosphate buffered saline (DPBS) followed by incu- 
bation with specific antibodies diluted into 0.5 % BSA in DPBS. Antibodies 
employed were H5, HI4, 8WGI6, and MOPC 104 described under Western 
blotting above as well as ARNA 3 (Research Diagnostics,  Flanders, NJ) and 
SC35 (Fu and Maniatas, 1990) generously provided by T. Maniatas of Har- 
vard University.  Specific  antibody binding was  visualized  by incubating 
washed  coverslips  with fluorescein  conjugated  anti-IgM or rhodamine- 
conjugated anti-IgG diluted into 0.5% BSA in DPBS (Vector Labs, Burlin- 
game,  CA).  In Fig.  6  G,  MDCK cells grown on glass coverslips  were 
washed and extracted with TD buffer before fixation with 1.75% parafor- 
maldehyde.  For this application the EDTA was omitted and the buffer was 
adjusted to 2 mM MgCI2 in order to maintain cell-substrate adhesion and 
nuclear integrity. 
Alkaline Phosphatase Treatment 
Proteins immunoprecipitated with HI4 coupled to protein G  Scpharose 
beads as described above were washed with 20 mM Hepes, pH 7.3, 20 mM 
MgC12, 40 mM KCI, 0.2 mM PMSF (Rice and Spencer,  1994). The im- 
munoprecipitate was then exposed  to calf intestine alkaline phosphatase 
(New England Biolabs,  Beverly, MA) at a concentration of 500 U per ml 
in a volume of 75/~1 (excluding bead volume) in the presence or absence 
of the phosphatase inhibitor # glycerophosphate  (5 mM) for 5 min at 37"C. 
The reaction was stopped and the proteins were eluted from the beads by 
adding 4× sample buffer and boiling for 5 rain. The elnted proteins were 
analyzed  by SDS-PAGE and Western  immunoblot analysis  as described 
above. 
Fractionation of  Pol H LS 
For Western immunoblot analysis,  MDCK cells grown on 100-mm dishes 
were subjected to appropriate drug treatments,  washed 3 ×  with TBS, and 
incubated with ice cold TD buffer at 4°C for 15 rain. Cell extracts were 
scraped into 2-ml microcentrifuge tubes, subjected to mechanical disrup- 
tion by 10 passages through a 23-gauge needle, and centrifuged at 16,000 g 
for 20 rain. The insoluble material was resuspended in 2 ml of 2x sample 
buffer (see immunopurification  above) and the supernatant was diluted to 
2 ml with 1 ml of 4× sample buffer. The two fractions were then subjected 
to 6% SDS-PAGE followed by immunoblot analysis. 
Results 
Monocional Antibodies that Bind Specifically to the 
Large Subunit of  RNA Polymerase H 
Previous studies using mammalian cells showed that mAbs 
H5 and H14 immunostain nuclear speckles that are enriched 
with splicing proteins,  and that they immunoblot a major 
protein species at ,v240 kD and a minor species at 210 kD 
(Warren et al.,  1992;  Bregman et al.,  1994).  This protein 
was  called  "cytostellin"  to  describe  its  stellate  pattern  of 
immunoreactivity  in  mitotic  cells  (Warren  et  al.,  1992). 
Cytostellin  was  immunopurified  from  DNAse  treated  rat 
liver nuclei using mAb H5 (see Materials and Methods). In 
some experiments cytostellin was extracted by boiling in 1% 
SDS, diluted, and then immunoprecipitated with mAb H5 to 
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other  experiments  cytostellin  was  extracted  under  non- 
denaturing conditions,  yielding a  complex with prominent 
bands that migrate at 240 kD and 140 kD on PAGE (Fig.  1 
A).  The p240 and p140 bands were excised, digested with 
trypsin in situ and subjected to HPLC to resolve the resulting 
peptides.  Amino acid  sequences of three peptides derived 
from p240 exactly match residues 430-444,  919-927,  and 
1059-1074  of the largest subunit of murine RNA polymerase 
II (Fig.  1 B). The amino acid sequence of a peptide derived 
from p140 matches exactly with residues 137-145 of the sec- 
ond largest subunit of RNA Polymerase II (Fig.  1 B). Addi- 
tional coprecipitating proteins below 45 kD have not been se- 
quenced (Fig.  1 A, asterisk).  Thus, cytostellin is the largest 
subunit of RNA polymerase 11 (Pol 1I LS). 
To confirm that mAbs H5 and H14 recognize Pol II LS, 
separate aliquots of p240 immunoprecipitated with each an- 
tibody were immunoblotted with rnAb H5, mAb H14, mAb 
MOPC  104  (control  IgM),  and  a  commercially available 
anti-Pol II LS mAb, 8WG16 (Fig.  1 C). mAbs H5 and H14 
specifically  immunoprecipitate  the  same  240-kD  protein 
(Fig.  1 C, left two panels),  which is also recognized on im- 
munoblots by the anti-Pol II LS mAb 8WG16 (Fig.  1 C, far 
right panel).  Pol  II LS  that  was  immunoprecipitated  by 
8WG16 also binds specifically to mAbs H5 and H14 on im- 
munoblots  (data  not  shown).  The  control  mAb  H22  im- 
munoprecipitates a '~180-kD protein (unpublished observa- 
tions) that is not recognized by mAbs H5, H14, or 8WG16, 
and the control, mAb MOPC  104, does not bind Pol II LS 
or the ~180-kD protein (Fig.  1 C). 
Figure  1.  Cytostellin  is  the  largest 
subunit of RNA Polymerase II. (A) Im- 
munopurification of"cytostellin" and as- 
sociated proteins.  Rat liver nuclear ex- 
tracts were prepared as described in the 
Materials  and  Methods  and  incubated 
with mAb H5 overnight. Immune com- 
plexes  were  collected  using  rabbit 
anti-mouse IgM linked to Streptococcal 
protein  G-agarose  beads.  The  beads 
were washed, solubilized in SDS sample 
buffer and resolved by 8% SDS-PAGE. 
The  p240  and  p140 proteins  are  in- 
dicated.  #,  mouse  IgM  heavy  chain; 
-y, rabbit  IgG heavy chain;  lc,  immu- 
noglobulin  light chains.  Asterisks,  un- 
identified  coimmunoprecipitating  pro- 
teins.  The  relative  mobilities  (Mr) of 
the molecular weight standards are indi- 
cated  in kilodaltons  (kD).  (B) Tryptic 
Peptide  Sequences.  Coomassie-stained 
p240 and p140 bands were excised, tryp- 
sin digested,  and  subjected  to HPLC. 
The amino acid sequences of 3 tryptic 
peptides  derived  from p240, and  one 
tryptic  peptide  from p140 are shown. 
Superscript  numbers  indicate  amino 
acid positions of  the first and last residue 
of each peptide as aligned with mouse 
RNA  polymerase II  (GenBank).  (C) 
Monoclonal antibodies H5 and H14 bind 
to  RNA  polymerase  II.  Extracts  of 
MDCK cells were immunoprecipitated 
with mAb H22, mAb H14, or mAb H5 
as described in Materials and Methods. 
Washed immunoprecipitates  and whole 
cell  extracts  (WC)  were  subjected  to 
SDS-PAGE,  transferred  to  nitrocellu- 
lose and immunoblotted with mAb H5, 
mAb H14, MOPC 104 (control IgM), or 
8WG16. Blots were developed using the 
ECL  ®  nonisotopic  detection  system 
(Amersham).  The 240-kD band (Pol II 
LS) is indicated at left margin.  IB, im- 
munoblotting mAbs. IP, immunoprecipi- 
taring mAbs./z and ~, immunoglobulin 
heavy  chains.  The  relative  mobilities 
(Mr) of the molecular weight standards 
are indicated in kilodaltons (kD). 
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but also many additional proteins in whole cell extracts (Fig. 
1 C, far right panel,  WC).  In contrast, mAbs H5 and H14 
bind exclusively to Pol II LS (Fig. 1 C, left twopanels, WC). 
Both of these mAbs bind to a "o240-kD band in whole cell 
extracts from all eukaryotes tested from human to C. elegans 
(Warren et al., 1992),  and they specifically immunoprecipi- 
tate and immunoblot a single "o210-kD  protein (Pol II LS) 
from extracts of S. pombe and S.  cerevisiae  (unpublished 
data). Therefore, rnAbs H5 and H14 bind to epitope(s) that 
are present in Pol II LS molecules from a vast evolutionary 
spectrum of eukaryotic organisms. 
mAbs 1t5, 1-114, and 8WG16 Recognize Different 
Phosphorylated Forms of  Pol H LS 
All known phosphorylation sites on Pol II LS have been 
mapped to the CTD, which is comprised of 52 tandem hep- 
tapeptide repeats similar or identical to the sequence Tyr- 
Ser-Pro-Thr-Ser-Pro-Ser  (for  reviews  see  Corden,  1990; 
Sawadago and Sentenac,  1990;  Young,  1991; Dahmus and 
Dynan, 1992; Zawel and Reinberg, 1993). Two major phos- 
phorylated forms of Pol II LS have been defined in mam- 
malian cells: Pol II0 is hyperphosphorylated predominantly 
on Ser and Thr residues in the CTD, and it is recognized by 
a  SDS-PAGE  mobility of ,o240 kD; Pol IIA is hypophos- 
phorylated, and it migrates at  ,o220 kD  (Dahrnus,  1981; 
Bartholomew et al.,  1986;  Zhang and Corden,  1991; Dah- 
mus and Dynan, 1992).  Pol II0 and Pol IIA are believed to 
have distinct functional roles in transcriptional initiation and 
elongation, but the exact function of CTD phosphorylation 
remains unknown (see Discussion). 
Each mAb used in this study binds differently to Pol II0, 
Pol IIA, and the multiple intermediate forms of Pol II LS 
(Fig. 2 A). mAb H5 immunoblots exclusively to Pol II0 in 
whole cell extracts (Fig. 2 A). mAb H14 binds well to Pol 
II0,  Pol IIA (220  kD),  and multiple intermediately phos- 
phorylated forms between 220 and 240 kD (Fig. 2 A). mAb 
8WG16 binds preferentially to hypophosphorylated forms of 
Pol II LS, including Pol IIA (Fig. 2 A). To determine whether 
mAbs  H5  and H14  bind to phosphorylated epitopes,  Pol 
II0 was inununoprecipitated from cells with mAb H5 and in- 
cubated with increasing concentrations of alkaline phospha- 
tase (Alk~). After incubation, each sample was divided into 
three aliquots, which were subjected to PAGE and immuno- 
blotted with mAb 1-15, mAb H14, or mAb 8WG16 (Fig. 2 B). 
mAb H14 binds to a series of bands ranging from "o240 kD 
to "o230 kD. Increasing concentrations of AlkcI, lead to an 
increased electrophoretic mobility of Pol II LS, and a  re- 
duced intensity of mAb H14 binding. Our interpretation of 
this result is that increasing concentrations of Alk~ remove 
increasing numbers of phosphate groups from multiple re- 
iterated H14  epitopes.  Presumably, 50 Kunitz units/ml is 
sufficient  to dephosphorylate all of  the H14 epitopes, thereby 
abrogating mAb H14 binding. Increasing concentrations of 
Alk~ reduce mAb H5 binding to Pol II0, but mAb H5 does 
not detect the hypophosphorylated forms ofPol II LS, which 
migrate faster than 240 kD. Our interpretation of this result 
is that mAb H5 binds to a phosphorylated epitope(s) that is 
less reiterated than the epitopes recognized by mAb H14. 
mAb gWG16 binds to a spectrum of phosphorylated forms 
of Pol II LS, and its binding is increased by Alk~ treatment, 
indicating that this mAb binds preferentially to hypophos- 
phorylated forms ofPol II LS (Fig. 2 B). A Ser/Thr phospha- 
tase inhibitor, fl-glycerophosphate, blocks all of these effects 
of Alk4~ (Fig. 2 B, flGP). Rephosphorylation of Pol U LS 
with casein kinase restores binding of mAbs H5 and H14 to 
Pol II LS (unpublished results). The above results show that 
mAbs H5 and H14 bind only to phosphorylated forms of Pol 
II LS, and indicate that they bind to different epitopes on Pol 
II LS's CTD, the domain which contains all known Pol II LS 
phosphorylation sites.  Detailed mapping of the H5 and H14 
epitopes will be published elsewhere (manuscript in prep- 
aration). 
A  Subpopulation ofPol H LS Is Tightly Associated 
with Discrete Nuclear Speckles 
The ability to detect Pol II LS in speckle domains is influ- 
enced by several factors. First, the intensity speckle labeling 
by mAb H5 fluctuates during the cell cycle. Thus, unsyn- 
chronized cell nuclei are stained heterogeneously by mAb 
H5:  most have a diffuse nucleoplasmic Pol II LS-staining 
pattern (Fig. 3 A, first panel from left).  However,  "o20% of 
the cells also have 20-50 discrete speckles, which colocalize 
with splicing protein SC35 and snRNPs of the pre-mRNA 
splicing class (Bregman et al.,  1994).  The speckled pattern 
is most pronounced in early G1 daughter cell nuclei (Breg- 
Figure 2. Monoclonal antibodies recognize different phosphorylated forms of Pol II LS. (A) Immunoblot analysis of whole cell extracts. 
MDCK cells were immediately boiled in SDS sample buffer, subjected to 6% PAGE, and immunoblotted  with mAbs H5, H14, and 8WG16. 
mAb 1-15 binds exclusively  to Pol II0 at ,~240 kD. mAb H14 binds to Pol II0, Pol HA, and multiple intermediately phosphorylated forms 
of Pol II IS. 8WG16 binds preferentially to hypophosphorylated forms of Pol II IS including Pol IIA. Dots indicate discrete bands. (B) 
In vitro dephosphorylation of Pol II LS. Pol II LS was immunoprecipitated  from MDCK cells with mAb H5 and divided into three parts, 
which were incubated for 5 rain at 37°C in various concentrations of alkaline phosphatase (Alk,~), or alkaline phosphatase plus/~-glycero- 
phosphate (Alk~ + ~-GP). Samples were then boiled in SDS buffer, subjected to 6% PAGE, and immunoblotted with mAb H5, H14, 
or 8WG16. Dots indicate positions of Pol II0 and Pol IIA. 
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of Pol II  LS  in control  and 
c~-amanitin-treated cells.  (A) 
Different patterns of intranu- 
clear Pol II LS immunoreac- 
tivity. Exponentially growing 
MDCK cells were fixed and 
immunostained  with  control 
IgM (C), mAb HI4, mAb H5, 
or mAb 8WG16 as described 
in  Materials  and  Methods. 
The third panel from the left 
was preextracted in 1.5 % Tri- 
ton X-100  before fixation, and 
then  immunostained  with 
mAb H5.  All anti-Pol 1I LS 
mAbs stain the diffuse nucleo- 
plasmic compartment, but in 
'~20% of cell nuclei mAb H5 
stains an additional fraction of 
Pol H LS localized in 20-50 
"speckles" (arrowheads, 2nd 
and 3rd panels from left). If 
the  cells  are  extracted  with 
Triton  X-100 before  fixation 
and permeabilization,  nearly 
all cell nuclei have a speckled distribution of Pol II LS as determined by mAb H5 immunostaining (see Fig. 3 B). mAb 8WG16 stains 
2-5 "dots" in over 50% of cell nuclei (arrowheads, fifth panel from left). (B) Control cells (No Tx) and c~-amanitin-(c~-Am)  treated cells 
were prepared for immunostaining by two protocols. In the preextraction/fixation  protocol (P/F), cells were extracted with 1% Triton X-100, 
and then fixed with 1.75  % paraformaldehyde. In the fixation/permeabilization  protocol (F/P), cells were fixed with 1.75  % paraformaldehyde 
and permeabilized with 0.5 % Triton X-100 (see Materials and Methods). Subsequently, cells were immuostained with antibodies directed 
at SC35 (SC35) or Pol H LS (H5 or HI4), and then visualized using goat anti-mouse IgM or IgG secondary antibodies linked to fluorescein 
isothiocyanate (FITC). Arrowheads in control panels (No Tx) indicate irregularly shaped nuclear speckles with apparent interconnections. 
Arrowheads in c~-amanitin (~x-Am) panels indicate enlarged round speckles without apparent interconnections. Bar, 10 #m. 
man et al., 1994); an example of this pattern is shown in Fig. 
3 A, second panel from left. Second, growth factor stimula- 
tion induces a rapid "burst" of intranuclear mAb H5 immu- 
noreactivity which facilitates visualization of Pol II LS in the 
speckles (Bregman et al.,  1994). Third, speckles are more 
easily visualized when the diffuse nucleoplasmic fraction of 
Pol 1I LS is extracted with nonionic detergents before fixation 
and mAb H5 immunostaining; an example of a nucleus pre- 
extracted with 1.5% Triton X-100 is shown in Fig. 3 A, the 
third panel from the left. In fact, if a population of cells is 
preextracted with  1.5%  Triton X-100,  and then fixed and 
stained with mAb H5,  nearly all nuclei have an intercon- 
nected speckled pattern (see Fig. 3 B). Taken together, the 
above results show that Pol II LS is detected in the speckles 
using mAb H5, but only under certain conditions. 
The speckle bound subpopulation of Pol II LS is difficult 
to detect using mAbs that bind to other Pol II LS epitopes. 
rnAb  H14  stains  speckle domains  in  transcriptionally in- 
hibited cells (Fig. 3 B, HI4, or-Am), but under ordinary con- 
ditions it strongly labels the diffusely distributed fraction of 
Pol H LS without revealing speckle domains (Fig. 3 A). A 
commercially available anti-Pol H LS rnAb, ARNA3 (Krii- 
mer et al.,  1980),  weakly stains  Pol H  LS in the diffuse 
nucleoplasmic compartment, but not in the speckles (Fig. 3 
A). mAb 8WG16 stains the diffuse nucleoplasmic compart- 
ment,  but in over 50%  of nuclei it also  stains  '~3-5  in- 
tranuclear dots  (Fig.  3 A,  arrowheads).  The above study 
shows that different anti-Pol II LS antibodies immunostain 
nuclei with different patterns. 
~-Amanitin Induces a Detergent-resistant 
Fraction of  Pol II LS to Redistribute to Enlarged 
Sgeclae Domains 
ot-Amanitin, a compound that completely blocks Pol ll-medi- 
ated transcription  (Lindell et al.,  1970),  induces a  strik- 
ing  accumulation  of SC35  in  multiple  intranuclear  dots, 
which lack apparent interconnections (O'Keefe et al., 1994). 
These dots  have the ultrastructural  characteristics  of en- 
larged ICG clusters; their expansion appears to result from 
the recruitment of splicing proteins from the PCFs to the 
ICGCs (O'Keefe et al.,  1994).  The redistribution of SC35 
from PCFs to ICGCs correlates with the loss of interconnec- 
tions between the speckles, which is evident at the light mi- 
croscopic  level of resolution.  To  distinguish  the  dot-like 
structures  in transcriptionally inhibited cells from the ir- 
regularly shaped speckle domains in transcriptionally active 
control cells, the former are referred to as "enlarged speckle 
domains; and the latter are referred to as "interconnected 
speckle domains." 
The finding that a detergent-resistant fraction of Pol II LS 
colocalizes with SC35 in control cells (Bregman et al., 1994) 
prompted us to ask whether this fraction of Pol II LS redis- 
tributes with SC35 to enlarged nuclear speckles in response 
to o~-amanitin (Fig. 3 B). To ascertain whether or not Pol II 
LS molecules are resistant to detergent extraction, cells were 
prepared for antibody staining using two protocols:  (a) a 
standard fixation/permeabilization protocol (F/P), and (b) a 
1% Triton X-100 preextraction/fixation  protocol (P/F), which 
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fixation (see Materials and Methods). Control (No 1~x) and 
ct-arnanitin-treated (a-Am)  cells  were  processed  by  each 
protocol  and  immunostained with mAbs  directed against 
SC35 or Pol II LS. 
SC35 is distributed in speckles that appear to be intercon- 
nected in control cell nuclei prepared by either protocol (Fig. 
3 B, SC35, No Tx). ot-Amanitin induces SC35 to redistribute 
to  enlarged  speckles  lacking  interconnections  (Fig.  3  B, 
SC35, ~Am).  The enlarged speckle pattern of SC35 is re- 
vealed by P/F and F/P protocols.  In contrast, the pattern 
of Pol II LS immunoreactivity is different in control cells 
prepared by the two protocols. All cells prepared by the F/P 
protocol have a diffuse nucleoplasmic pattern Pol II LS im- 
munoreactivity when stained with mAb  H14.  When cells 
prepared by F/P protocol are stained with mAb H5, *80% 
have a diffuse nucleoplasmic pattern immunoreactivity and 
*20%  have a speckled pattern (not shown here).  The P/F 
protocol extracts the diffuse fraction of Pol II LS, so when 
these cells are immunostained with mAb H14,  little if any 
Pol II LS is detected (Fig. 3 B, H14, No Tx). Pol II LS in the 
extract and residue can be easily detected by immunoblotting 
with mAb H14, so the loss of staining is not due to proteoly- 
sis  or dephosphorylation (data  not shown).  Significantly, 
when cells prepared by the P/F protocol are immunostained 
with mAb H5,  nearly every nucleus has an interconnected 
speckle pattern (Fig. 3 B, H5, No Tx). This speckle bound 
fraction of Pol II LS colocalizes with SC35 at the light micro- 
scopic level of resolution (Figs. 4 and 5). 
Pol  II  LS redistributes  to enlarged speckle domains in 
ct-amanitin-treated cells, as revealed by mAbs H5 and H14, 
which recognize different epitopes in Pol II LS's CTD (Fig. 
3 B, H5 and 1-114, or-Am). Significantly, the redistribution of 
Pol II LS is revealed using the P/F and F/P protocols, indicat- 
ing that: (a) the pattern of Pol II LS immunoreactivity in- 
duced by ot-amanitin  is not distorted by the preextraction 
step; and (b) Pol II LS is tightly associated with the enlarged 
speckle domains. Pol II LS located in the enlarged speckles 
of o~-amanitin-treated  cells is not detected by anti-Pol II mAb 
ARNA3 or mAb  8WG16. A  possible explanation for this 
finding is offered in the Discussion. Finally, other nuclear 
proteins including hnRNP A1 and C do not redistribute to 
speckles in response to a-amanitin (unpublished data). In 
summary, there are two populations of Pol II LS, which can 
be distinguished by differences in their intranuclear distribu- 
tion,  detergent  solubility  properties  and  accessibility  to 
monoclonal antibodies. 
Multiple Transcriptional Inhibitors Induce Pol H LS 
and SC35 to Redistribute to Enlarged Speckles 
ot-Amanitin  inhibited transcription involves direct binding 
of this compound to Pol II LS (for a  review see Roeder, 
1976),  raising the possibility that drug-bound,  inactivated 
Pol II LS precipitates in the enlarged speckles. Therefore, we 
sought evidence that Pol II LS and SC35 redistribute to en- 
larged speckles in response to other transcriptional inhibi- 
tors, including compounds which inhibit Pol II indirectly. To 
test this idea, SC35 and Pol II LS were simultaneously im- 
munolocalized in cells treated with four agents that arrest Pol 
II-mediated transcription. In Fig. 4, control and transcrip- 
tionally  inhibited  cells  were  double  stained  with  SC35, 
Figure 4. Diverse Pol II transcription transcriptional inhibitors in- 
duce SC35 and Pol II LS to redistribute to an enlarged speckled 
pattern.  Cells were extracted with  1%  Triton X-100, fixed with 
1.75 % paraformaldehyde, and double immunostained with mAbs 
H5 and SC35. Pol II mAb H5 was visualized  with a goat anti-mouse 
IgM-fluorescein isothiocyanate (FITC) conjugate (upper panels) 
and  mAb  SC35 was  visualized using goat  anti-mouse  IgG- 
rhodamine conjugate (lower  panels). Note that control cell nuclei 
(No Tx) have irregularly shaped speckles with apparent intercon- 
nections, whereas transcriptionally inhibited cells have enlarged 
round speckles lacking apparent interconnections. Essentially the 
same redistribution is observed when cells were fixed with 1.75  % 
paraformaldehyde, and  then  permeabilized  with  0.5% Triton 
X-100. Bar, 10 #m. 
which is detected by a rhodamine-linked secondary antibody 
(lower  panels),  and  Pol  II  LS,  which  is  detected  by  a 
fluorescein-linked antibody (upper panels).  Treatments in- 
clude transcriptional inhibitors with different  mechanisms of 
action: ot-amanitin (u-Am), DRB (Tamm et al.,  1976; Seh- 
gal  et  al.,  1976;  Zandomeni  et  al.,  1986;  Stevens  and 
Maupin, 1989; Chodosh et al., 1989), N-(2-[methylamino]- 
ethyl)-5-isoquinoline-sulfonamide  (H8; Serizawa, 1993) and 
actinomycin-D (Act-D; Perry and Kelley,  1970).  All of the 
above agents induce SC35 and Pol II LS to redistribute to 
the enlarged speckles; in each case the interconnections be- 
tween the enlarged speckles have disappeared or diminished 
(Fig. 4). All agents induce this effect in ~95 % of interphase 
cells. Significantly, Pol U LS and SC35 are tightly associated 
with the enlarged speckles as indicated by their resistance to 
detergent extraction. The redistribution is observed in cells 
prepared by the F/P protocol, indicating that the preextrac- 
tion step does not lead to artifactual staining patterns (un- 
published data). In summary, transcriptional inhibitors acting 
by different mechanisms can induce Pol II LS and splicing 
proteins to relocate to enlarged speckle domains. 
lntranuclear Redistribution of  Pol H LS and SC35 Is 
Reversible and Temperature Dependent 
DRB is an adenosine analogue that blocks Pol II transcrip- 
tion in part by its ability to inhibit protein kinases which 
phosphorylate Pol II LS's CTD, a putative regulatory region 
of Pol II LS (Zandomeni et al., 1986; Stevens and Maupin, 
1989;  Chodosh et al.,  1989; also see below). DRB rapidly 
penetrates cell membranes, and it can be rapidly washed out 
to  reverse the transcriptional block (Tamm et al.,  1976). 
Using DRB washout experiments, the redistribution of Pol 
II LS and SC35 are shown to be reversible and temperature 
dependent (Fig. 5). After a 3-h DRB treatment, Pol II LS and 
SC35 redistribute from their usual speckled pattern to en- 
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versible and temperature dependem. Three dishes of MDCK cells 
were treated with DRB (DRB) for 3 h. In two of the dishes, DRB- 
containing  medium was  thoroughly  washed out  with  complete 
medium; one dish was incubated for an additional hour at 37°C, 
and the other at 4°C before fixation and double immunostaining 
with mAbs SC35 and H5. SC35 was visualized with rhodarnine- 
conjugated goat anti-mouse IgG (lower  panels), and mAb H5 was 
visualized with goat anti-mouse  IgM conjugated to FITC (upper 
panels). Note the irregular multifocal mAb H5 immunostaining in 
the control cell nucleus (No Tx, H5), which overlaps with the inter- 
connected speckled pattern of SC35 (No Tx, SC35). Arrowheads 
indicate enlarged speckles that are coimmunostained by mAbs H5 
and SC35 (DR.B, H5, and SC35; DRB washout at 4°C, H5, and 
SC35). Enlarged speckles are not observed 1 h after DRB washout 
at 37°C. Bar, 10/~m. 
larged speckles lacking interconnections (Fig.  5, No Tx vs 
DRB). Separate dishes of cells were subjected to the same 
DRB treatment, followed by DRB washout and incubation at 
37°C or 4°C for an additional hour (Fig. 5,  Washout). The 
cells were preextracted with 1% Triton X-100, fixed, and im- 
munostained  with mAb  H5  or  SC35  so that  the  speckle 
bound fraction of Pol II LS could be optimally visualized. 
SC35 and Pol II LS are sequestered in the enlarged speckles 
when the cells are maintained at 4°C (Fig. 5, l~lshout, 4°C, 
arrowheads).  However,  when  the  cells  are  incubated  at 
37°C,  Pol  11  LS  and  SC35  relocate  from  the  enlarged 
speckles to a  distribution that is similar to untreated ceils 
(Fig.  5,  Washout, 37~C).  Time course experiments have 
shown that Pol II LS and SC35 redistribute simultaneously, 
beginning <15 min after the DRB is removed (unpublished 
data).  The  temperature  dependent,  synchronous  intranu- 
clear redistribution of Pol II LS and SC35 suggest that these 
proteins are shuttled by a common mechanism that requires 
energy. 
Speckle-Bound Pol H LS Is Hyperphosphorylated on 
the COOH-Terminal Domain 
The immunolocalization studies with mAb H5 (a Pol II0- 
specific antibody) indicate that the subpopulation of Pol II 
LS which remains in the speckle domains after Triton X-100 
extraction is hyperphosphorylated on the CTD (Fig,  3 A). 
This observation prompted us to explore the possibility that 
Pol II LS's resistance to detergent extraction and its localiza- 
tion to speckle domains are correlated with a high degree of 
CTD phosphorylation. First, we established extraction con- 
ditions that optimally fractionate Pol II0 from Pol I/A and 
other hypophosphorylated forms of Pol 1I LS. None of the 
conditions we tried yielded fractions containing exclusively 
one phosphorylated form ofPol II LS; however, Pol I/A and 
intermediately hypophosphorylated species of Pol II LS are 
more readily extracted than Pol II0 in 0.5%  Triton/0.5% 
deoxycholate  (TD  buffer;  see  Materials  and  Methods). 
Therefore, TD-soluble and TD-insoluble fractions were ana- 
lyzed by immunoblotting with mAbs HS, H14, and 8WG16 
to compare the solubility properties of Pol II0, Pol IIA, and 
intermediately phosphorylated forms of Pol I/LS. In addi- 
tion,  TD-extracted nuclear  residues  were immunostained 
with  mAb  H5  to  visualize the  subnuclear distribution of 
speckle-bound Pol II0 in control and transcriptionally in- 
hibited cells. 
TD supernatant (S) and pellet (P) fractions prepared from 
control cells were immunoblotted with mAbs H14, H5, and 
8WG16 (Fig. 6, A-C). Various hypophosphorylated forms of 
Pol II LS between '~240 and 220 kD are almost completely 
extracted, as indicated by mAbs H14 and 8WG16. A similar 
spectrum of hypophosphorylated forms is detected in whole 
cell extracts prepared by immediate boiling in SDS sample 
buffer with  phosphatase  inhibitors,  indicating  that  hypo- 
phosphorylation does not take place during extraction with 
TD buffer (Fig. 2 A). Significantly, the TD pellets contain 
the Pol II LS molecules that have the most retarded elec- 
trophoretic mobility (Fig. 6, A and B; Control),  whereas the 
TD supernatants  contain Pol II LS molecules that have a 
spectrum of electrophoretic mobilities <240 kD. Note that 
Pol  U  LS  molecules  in  the  pellet  fraction  have  a  more 
retarded electrophoretic mobility than the slowest migrating 
Pol II LS molecules in supernatant fractions (Fig. 6, A and 
B; Control). 
DRB is a CTD kinase inhibitor in vitro and in vivo (Zan- 
domeni et al.,  1986; Stevens and Maupin,  1989; Chodosh 
et al.,  1989; Dubois et al.,  1994). Exposure of cells to 100 
/zM DRB for 3 h results in the appearance of multiple par- 
tially hypophosphorylated forms of Pol 1I LS (Dubois et al., 
1994). The DRB-induced, hypophosphorylated forms of Pol 
II LS are nearly completely extracted in TD buffer as shown 
in the blots probed with mAbs H14 and 8WG16. mAb H5 
does not recognize these forms in the supernatant fraction 
(Fig. 6  B; DRB).  After a  3-h treatment in  100/~M DRB, 
some Pol II0 remains; significantly, nearly all of this Pol II0 
resists TD extraction (Fig. 6, A and B; DRB). 
DRB induces dephosphorylation of the CTD in a fraction 
of Pol II LS molecules; simultaneously, mAb H5 immuno- 
staining disappears  from the diffuse compartment and in- 
tensifies in the enlarged speckle domains (Figs.  4  and 5). 
One possible explanation is that hypophosphorylated Pol II 
LS  molecules  redistribute  from the  diffuse compartment 
to the enlarged speckle domains.  According to this  idea, 
hypophosphorylated  Pol II LS molecules may be sequestered 
in enlarged speckle domains with the spliceosomal proteins 
that are not engaged in splicing. This seems reasonable, es- 
pecially given that Pol II0 has been identified as the actively 
elongating form of Pol II LS in vivo (O'Brien et al.,  1994). 
However we do not favor this hypothesis because (a) the en- 
larged speckle domains in DRB-treated cells are visualized 
by mAb H5, a Pol I/0-specific mAb (Figs. 4 and 5); (b) Pol 
IIA and the other hypophosphorylated forms of Pol II LS re- 
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II LS is hyperphosphorylated 
on  the  CTD. (A-D)  Equal 
numbers of  control, DRB, and 
et-amanitin-treated  MDCK 
cells were fractionated in TD 
buffer into soluble (S) and in- 
soluble  (P)  fractions  as  de- 
scribed  in  Materials  and 
Methods. Supernatant (S) and 
pellet (P) fractions were solu- 
bilized in SDS sample buffer, 
subjected  to  6%  PAGE and 
immunoblotted  with  mAbs 
H14 (A and D), H5 (B), and 
8WG16 (C). In all cases, the 
pellet  fraction  contains  the 
most  hyperphosphorylated 
form(s) of Pol II LS that mi- 
grate as a sharp band at 240 
kD.  The  soluble  fraction  is 
comprised  of a  spectrum  of 
Pol  II  LS  forms  phos- 
phorylated to various degrees. 
Dots  in  A,  four  partially 
hypophosphorylated  species 
of Pol U LS. (E) In Control, DRB and ot-amanitin-(c~-Am)  treated cells, Pol II0 remains in the TD resistant nuclear residue in a speckled 
distribution. After TD extraction, residues were fixed and immunostained with the Pol II0-specific mAb H5. A goat anti-mouse IgM con- 
jugated to fluorescein isothiocyanate (FITC) was used to visualize the distribution of Pol II0. Bar, 10 #m. 
main in the diffuse nucleoplasm as indicated by immuno- 
staining DRB-treated cells with 8WG16, which preferentially 
recognizes hypophosphorylated  Pol II LS molecules (unpub- 
lished data); and (c) hypophosphorylated Pol II LS species 
accumulate in the TD supernatant fraction of DRB-treated 
cells (Fig. 6  C; compare S fraction in Control and DRB). 
Thus, neither the immunolocalization data or the biochemi- 
cal data supports the hypothesis that Pol II LS moves from 
the diffuse nucleoplasmic compartment (TD supernatant) to 
the speckle comparlment (TD residue) in response to DRB. 
These data suggest that DRB induces dephosphorylation of 
Pol II LS in the diffuse nucleoplasmic compartment, and that 
it independently induces a reorganization of the detergent in- 
soluble fraction of Pol II0: the subpopulation of Pol II0 in 
an interconnected speckled pattern appears to redistribute to 
an enlarged speckled pattern during states of transcriptional 
inhibition. 
a-Amanitin  inhibits  Pol  H-mediated transcription  by  a 
mechanism that does not involve dephosphorylation of the 
CTD.  As  expected, Pol II LS extracted from control and 
ct-amanitin-treated cells has an indistinguishable PAGE mo- 
bility (unpublished results). When ot-amanitin-treated cells 
are extracted in TD buffer, Pol II0 fractionates with the resi- 
due (Fig. 6 D, P) and less phosphorylated forms of Pol II 
LS are completely soluble (Fig. 6 D, S). Thus, in control, 
DRB and ot-amanitin-treated cells, the TD pellet contains 
exclusively Pol II0,  whereas the TD supernatant contains 
multiple phosphorylated forms of Pol II LS. 
To visualize the tightly bound fraction of Pol II0, TD ex- 
tracted nuclear residues (i.e., TD pellet fraction) from con- 
trol,  DRB-treated and  ot-amanitin-treated cells  were  im- 
munostalned with mAb H5. Pol II0 remains attached to the 
speckle  domains,  thereby  corroborating  the  biochemical 
data (Fig. 6 E, DRB). Interestingly, Pol II0 is distributed in 
speckles lacking interconnections in the nuclear residues of 
c~-amanitin- and DR.B-treated cells, but it is distributed in an 
interconnected speckle pattern in control nuclear residues 
(Fig.  6 E,  or-Am and DRB).  Double immunofluorescence 
shows that Pol II0 and SC35 resist extraction by 0.5 % Triton 
X-100/0.5%  Doe,  and they colocalize in  the  speckles of 
control, DRB-treated, and c~-amanitin-treated cells (unpub- 
lished observations). 
Discussion 
New Anti-Pol H LS Reagents Detect a Cryptic 
Population of  Pol H LS in Speckle Domains 
The present study establishes that mAbs H5 and H14 bind 
exclusively to Pol II LS, and that a subpopulation of Pol II 
LS molecules is "hidden" in speckle domains, mAbs H5 and 
H14 bind to a major band at ,~240 kD and a minor band at 
,~210 kD in extracts prepared from mammalian, avian, am- 
phibian, fish, insect, and nematode cells; furthermore, both 
mAbs  bind  to  a  '~210-kD  protein  in  S.  pombe  and  S. 
cerevisiae (Warren et al.,  1992 and unpublished results). In 
retrospect, the electrophoretic mobility and striking evolu- 
tionary conservation of this protein might have provided an 
early clue that it is Pol II LS. However, before this protein 
was identified as Pol II LS, it had been localized to nuclear 
speckles which harbor multiple-splicing proteins (Bregman 
et al.,  1994), and to the axis of amphibian lampbrush chro- 
mosome loops-a pattern that is distinct from the "matrix" 
staining  pattern  of many  pre-mRNA  processing  proteins 
(Joseph  Gall,  personal  communication).  Previous  studies 
had not detected Pol II LS in speckle domains or B-snur- 
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1993; for review see Spector, 1993),  so the finding that this 
protein is 1%1 II LS was quite surprising. The data presented 
here show that the speckle domains, which have been known 
for several years to harbor spliceosomal proteins, also har- 
bor a key transcriptional protein, 1%1 II LS. 
Speckle-associated 1%1 II LS molecules are detected only 
by a subset of anti-1%l II LS mAbs, and only under certain 
conditions. A logical explanation of these results is that the 
speckle-bound 1%1 II LS molecules are partially masked by 
interactions with other macromolecules. Speckle domains 
are densely packed with ribonucleoproteip particles (RNPs), 
so it is expected that some epitopes of the constituent pro- 
teins are masked, and therefore inaccessible to antibodies. 
Consistent with this idea, the rnAbs used in the present study 
bind to widely separated sites within the 1%1 II LS molecule. 
ARNA3 binds to an epitope in the non-CTD part of 1%1 II 
LS (Kr'~ner et al.,  1980).  8WGI6 binds to a nonphosphor- 
ylated site in the NH~-terminal half of the CTD (Thompson 
et al., 1989; and our unpublished results), mAbs H5 and H14 
bind to ohe or more phosphorylated sites within the CTD 
(Fig. 2 and our unpublished results). It is possible that cer- 
tain epitopes in the CTD may be more exposed than other 
regions of 1%1 II LS, particularly when the molecules are 
tightly attached to the speckle domains. 
Pol II0 Is Stored in Enlarged Speckle Domains during 
States of Transcriptional Inhibition 
Speckles immunostained by SC35  lose their intercormec- 
tions and become enlarged during states of transcriptional 
inhibition (O'Keefe et al., 1994; Spector et al., 1991); there- 
fore, enlarged unconnected speckle domains are thought to 
be  storage and/or reasssembly sites for splicing proteins. 
The present study shows that in cells inhibited by diverse 
transcriptional inhibitors, 1%1 H LS and SC35  are coredis- 
tributed to the enlarged speckle domains. Thus, it appears that 
transcriptionally dormant 1%1 II LS can be stored in speckle 
domains. In transcriptionally active nuclei at certain stages of 
the cell cycle, a substantial fraction of 1%11I LS is located in 
storage/reassembly sites, while another fraction is located at 
sites of 1%1 H transcription in the adjacent nucleoplasm. The 
implication is  that 1%1 H  LS and splicing  proteins can be 
recruited from these storage sites to the sites of 1%1 H gene 
expression  as they are needed. 
Implications for the Organization of  RNA Polymerase 
II-mediated Transcription In Vivo 
Several studies indicate that the phosphorylation state of 1%1 
II LS's CTD correlates with its transcriptional activity in 
vitro (for reviews  see Dahmus and Dynan, 1992;  Corden, 
1993; Greenleaf, 1993). Hypophosphorylated 1%1 II LS (1%1 
HA) is efficiently recruited to transcription initiation com- 
plexes in vitro (Lu et al.,  1991; Kang and Dahmus, 1993), 
but the elongation phase of transcription is heralded by phos- 
phorlation of 1%1 II's CTD to yield 1%1 II0 (Bartholomew et 
al., 1986; Chestnut et al., 1987; Cadena and Dahmus, 1987; 
Payne et al., 1989; Laybourn and Dahmus, 1990).  In vivo, 
paused polymerases are primarily 1%1 IIA, but they are con- 
verted to 1%1 II0 as they enter a  stable elongation phase 
(O'Brien et al., 1994). In addition, highly active genetic loci 
on Drosophila polytene chromosomes are enriched with 1%1 
II0 (Weeks et al.,  1993).  These data imply that 1%1 II LS's 
CTD undergoes a phosphorylation/dephosphorylation  cycle 
which regulates (or reflects) 1%1 Irs cycle of transcriptional 
initiation, elongation, and termination. 
The present study shows that 1%1 IIA and intermediately 
phosphorylated forms of 1%1 II LS are diffusely distributed 
in the nucleus, whereas 1%1 II0 is tightly associated with dis- 
crete domains. The differential localization of 1%1 IIA and 
1%1 II0 seems to be functionally significant, given the evi- 
dence cited above that these forms of 1%1 II LS have distinct 
roles in transcription. However, 1%1 II0-rich domains labeled 
by mAb H5 do not necessarily represent clusters of tran- 
scriptionally elongating 1%1 II. Indeed, an important conclu- 
sion of  present study is that a subset ofPol II0 molecules can- 
not be engaged in transcriptional elongation. First, Pol II0 
is concentrated in enlarged round speckles during pharmaco- 
logically induced states of transcriptional inhibition. Tran- 
scription is unlikely to take place  in the enlarged round 
speckles-especially in the presence of o~-amanitin, DRB, or 
actinomycin D. Second, 1%1 II0 is most prominent in speckle 
domains when transcription is quiescent-during the M/G1 
and  G2/M  cell  cycle transition  points  (Bregman  et  al., 
1994).  Third, Pol II0 molecules are bound to multiple dot- 
like structures that are widely distributed throughout mitotic 
ceils, which are transcriptionally inactive. Finally, the level 
of 1%1 II0 is the same throughout the cell cycle, even though 
overall transcriptional activity fluctuates markedly during 
the cell cycle (Bregman et al., 1994).  These findings do not 
contradict data showing that 1%1 II0 is the actively transcrib- 
ing form of Pol II LS, but they do indicate the existence of 
a transcriptionally dormant fraction of 1%1 II0. In fact, if one 
considers the total population of 1%1 II LS molecules, hyper- 
phosphorylation of  the CTD correlates better with 1%1 II LS's 
detergent extractability properties and its intranuclear local- 
ization than its transcriptional activity. 
Recent studies indicate that each nucleus has 100-500 dis- 
crete  foci enriched with nascent 1%1 II transcripts;  these 
"transcript foci" were shown to be tightly associated with a 
solid phase nuclear structure, and they did not colocalize 
with  nuclear regions that are  most highly enriched with 
SC35 (Wansink et al., 1993; Jackson et al., 1993). The pres- 
ent study does not directly address the question of where ac- 
tively transcribing 1%1 II LS is localized in the mammalian 
cell nucleus. However, recent immunoelectron microscopic 
localization studies of transcriptionally active cell nuclei re- 
veal intense mAb H5 labeling in multiple discrete foci; some 
of these 1%1 II LS Rich Foci (PRFs) appear to be in direct 
contact with ICGCs,  while others are  separate  from the 
ICGCs (Spector, D., personal communication). The PRFs 
were identified by mAb H5 labeling, so they contain 1%1 II0. 
We are currently testing the idea that one set of these PRFs 
are sites of transcription, and another set of PRFs are sites 
of 1%1 II LS storage. 
The present study also has potentially significant implica- 
tions for cotranscriptional splicing. Pre-mRNAs are cotran- 
scriptionally spliced and packaged into RNP particles in di- 
verse eukaryotic nuclei (references given in Introduction). 
1%1 II LS, SC35, and other pre-mRNA processing molecules 
are coordinately recruited to 1%1 II gene templates intro- 
duced into the nucleus by transfection or infection (Bridge 
et al., 1993; Jim6nez-Garcia and Spector, 1993; Rice et al., 
1994).  The latter studies showed that splicing proteins are 
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they did not reveal the subnuclear origin of the recruited Pol 
II LS molecules. Here, we have demonstrated that Pol H LS 
is stored in discrete sites that are very near the storage sites 
for splicing proteins; furthermore, Pol H LS and SC35 redis- 
tribute between an enlarged speckle pattern and an intercon- 
nected speckle pattern coincident with changes in the overall 
transcriptional  activity of the nucleus. The finding that the 
storage sites of Pol II LS and splicing proteins are organized 
similarly in mammalian nuclei suggests the possibility that 
Pol H LS and splicing proteins may be recruited simulta- 
neously from these storage compartments to Pol II genes; 
this would allow spliceosomes to gain direct and immediate 
access to nascent pre-mRNA transcripts. 
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